In-silico docking revealed that flavonoids and terpenoids, such as quercetin and kaempferol, strongly bind to key cancer-related proteins like p53 and Bcl-2, suggesting their role in modulating cancer pathways. This evidence concerns the gene BCL2 and cancer.